Michael G. Borland
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 4
- NF-κB Signaling Pathways 4
-
- Peroxisome Proliferator-Activated Receptors 14
- Protein Degradation and Inhibitors 3
- Metabolism, Diabetes, and Cancer 3
- Retinoids in leukemia and cellular processes 2
-
- Inflammatory mediators and NSAID effects 5
-
- Lipid metabolism and disorders 3
- Co-authors
- Jeffrey M. PetersFrank J. GonzalezShantu AminArun SharmaBokai ZhuAndrew N. BillinTimothy M. WillsonJennifer E. Foreman
- Partner nations
- United StatesIndiaItaly
In The Last Decade
Michael G. Borland
16 papers receiving 505 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 175
- Molecular Biology 417
- Pharmacology 75
- Biochemistry 24
- Physiology 75
Countries citing papers authored by Michael G. Borland
This map shows the geographic impact of Michael G. Borland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Borland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Borland more than expected).
Fields of papers citing papers by Michael G. Borland
This network shows the impact of papers produced by Michael G. Borland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Borland. The network helps show where Michael G. Borland may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael G. Borland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2019 | 5 | |
| 3 | 2018 | 16 | |
| 4 | 2017 | 15 | |
| 5 | 2014 | 24 | |
| 6 | 2013 | 15 | |
| 7 | 2012 | 37 | |
| 8 | 2011 | 33 | |
| 9 | 2011 | 35 | |
| 10 | 2011 | 57 | |
| 11 | 2010 | 16 | |
| 12 | 2010 | 55 | |
| 13 | 2008 | 29 | |
| 14 | 2008 | 53 | |
| 15 | 2007 | 58 | |
| 16 | 2007 | 59 |
About Michael G. Borland
Michael G. Borland is a scholar working on Cancer Research, Pharmacology and Molecular Biology, having authored 16 papers that have together received 508 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (14 papers), Inflammatory mediators and NSAID effects (5 papers), Cancer, Lipids, and Metabolism (4 papers), NF-κB Signaling Pathways (4 papers), Lipid metabolism and disorders (3 papers), Protein Degradation and Inhibitors (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Cancer Research (175 citations), Molecular Biology (417 citations) and Pharmacology (75 citations). Michael G. Borland has collaborated with scholars based in United States, India and Italy. Frequent co-authors include Jeffrey M. Peters, Frank J. Gonzalez, Shantu Amin, Arun Sharma, Bokai Zhu, Andrew N. Billin, Timothy M. Willson, Jennifer E. Foreman, Christina Lee and Combiz Khozoie. Their work appears in journals such as Gastroenterology, Molecular Pharmacology and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.